Evaluation of fatty acid metabolism-related gene expression in non-alcoholic fatty liver disease
Evaluation of fatty acid metabolism-related gene expression in non-alcoholic fatty liver disease
批准号:
17590658
负责人:
NAKAMUTA Makoto
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Nonalcoholic fatty liver disease (NAFLD) is one of the most frequent causes of abnormal liver dysfunction and its prevalence has markedly increased. We previously evaluated the expression of fatty acid metabolism-related genes in NAFLD and reported changes in expression that could contribute to increased fatty acid synthesis in NAFLD. In the present study, we evaluated the expression of additional fatty acid metabolism-related genes in larger groups of NAFLD (n=26) and normal liver (n=10) samples. The target genes for real-time PCR analysis were as follows: acetyl-CoA carboxylase (ACC) 1, ACC2, fatty acid synthase (FAS), sterol regulatory element-binding protein lc (SREBP1c), and adipose differentiation-related protein (ADRP) for evaluation of de novo synthesis and uptake of fatty acids; carnitine palmitoyltransferase la (CPT1a), long-chain acyl-CoA dehydrogenase (LCAD), long-chain L-3-hydroxyacyl-coenzyme A dehydrogenase α (HADHα), uncoupling protein 2 (UCP2), straight-chain acyl-CoA … More oxidase (ACOX), branched-chain acyl-CoA oxidase (BOX), cytochrome P450 2E1 (CYP2E1), CYP4A11, and peroxisome proliferator-activated receptor (PPAR) α for oxidation in the mitochondria, peroxisome and microsome; superoxide dismutase (SOD), catalase, and glutathione synthetase (GSS) for antioxidant pathways; diacylglycerol O-acyltransferase 1 (DGAT1), PPARγ, and hormone sensitive lipase (HSL) for triglyceride synthesis and catalysis. In NAFLD, although fatty acids accumulated in hepatocytes, their de novo synthesis and uptake were up-regulated in association with increased expression of ACC1, FAS, SREBP1c, and ADRP. Fatty acids oxidation-related genes, LCAD, HADHα, UCP2, ACOX, BOX, CYP2E1, and CYP4A11, were all over-expressed, indicating that oxidation was enhanced in NAFLD, whereas the expression of CTP1a and PPARα was decreased. Furthermore, SOD and catalase were also over-expressed, indicating that antioxidant pathways are activated to neutralize reactive oxygen species (ROS), which are overproduced during oxidative processes. The expression of DGAT1 was upregulated without increased PPARγ expression, whereas the expression of HSL was decreased. Our data indicated the following regarding NAFLD : 1) Increased de novo synthesis and uptake of fatty acids lead to further fatty acid accumulation in hepatocytes. 2) Mitochondrial fatty acid oxidation is decreased or fully activated. 3) In order to complement the function of mitochondria (β-oxidation), peroxisomal (β-oxidation) and microsomal (ω-oxidation) oxidation was up-regulated to decrease fatty acid accumulation. 4) Antioxidant pathways including SOD and catalase were enhanced to neutralize ROS overproduced during mitochondria, peroxisomal, and microsomal oxidation. 5) Lipid droplet formation was enhanced due to increased DGAT expression and decreased HSL expression. Further studies will be needed to clarify how fatty acid synthesis is increased by SREBP1c, which is under the control of insulin and AMP-activated protein kinase. Less
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
NAFLDにおける脂肪酸代謝 別冊・医学のあゆみ NAFLDのすべて (西原利治 編)
NAFLD 中的脂肪酸代谢 分册:医学史 关于 NAFLD 的一切(西原俊晴主编)
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[西原利治, 大西三朗, 中牟田 誠]
通讯作者:
中牟田 誠
インスリン抵抗性とメタボリックシンドローム
胰岛素抵抗和代谢综合征
DOI:
--
发表时间:
2008
期刊:
影响因子:
--
作者:
[窪田直人, 他]
通讯作者:
他
NAFLDにおける脂肪酸代謝 別冊・医学のあゆみ NAFLDのすべて (西原利治編)
NAFLD 中的脂肪酸代谢 分册:医学史 关于 NAFLD 的一切(西原俊晴主编)
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[西原利治, 大西三朗, Isse K et al., 日浅陽一, 中牟田 誠]
通讯作者:
中牟田 誠
NAFLDのすべて
关于 NAFLD 的一切
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[西原利治, 大西三朗]
通讯作者:
大西三朗
脂肪酸代謝と肝障害 別冊・医学のあゆみ 消化器疾患-State of Arts II 肝・胆・膵(竹井謙之、川崎誠治 編)
脂肪酸代谢和肝脏疾病单独卷/病史消化系统疾病 - 艺术现状 II 肝脏、胆汁和胰腺(由 Kenyuki Takei 和 Seiji Kawasaki 编辑)
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[N.Mitsutake, et al., 中牟田 誠]
通讯作者:
中牟田 誠
共 7 条
Anti-monocyte Chemoattractant Protein-1 Gene Therapy Prevents Dimethylnitrosamine-induced Hepatic Fibrosis in Rats
-
批准号:12670498
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:2000
-
负责人:NAKAMUTA Makoto
-
依托单位:
Prevention of hepatic fibrosis by super-fibronectin
-
批准号:10670485
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:1998
-
负责人:NAKAMUTA Makoto
-
依托单位:
国内基金
海外基金
登录
查看更多内容
肝巨噬细胞Notch1信号调控肝细胞铁死亡促进NASH进展的机制研究
-
批准号:JCZRQNB202600718
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
RBM17 作为转录共激活因子下调 USP25 并促进 NASH 发生发展的机制研究
-
批准号:ZCLQN26H0301
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘佩浩
-
依托单位:
线粒体自噬紊乱在重金属镉促进NASH进展中的作用和机制及干预措施研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:刘聪
-
依托单位:
基于成像技术研究桃红四物汤抑制GLS1抗NASH的效应物质和作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:戚胜兰
-
依托单位:
双环醇干预SAA1介导的巨噬细胞活化改善NASH的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:贾姝
-
依托单位:
疏肝健脾化浊方通过抑制 MCJ 介导的肠
道菌群促进线粒体稳态缓解 NASH 的作
用和机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:谢维宁
-
依托单位:
SMIM30通过调控炎症促进NASH发生发展
的分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:杨金娥
-
依托单位:
外泌体RBP4招募髓源巨噬细胞M2型极化促进NASH炎癌转化的机制研究
-
批准号:MS25H200017
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:姚金梅
-
依托单位:
变分不等式和不动点理论在纳什(Nash)群体博弈的应用研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:冷震北
-
依托单位:
HSP20通过调控肝脏巨噬细胞“线粒体自噬-炎症”轴影响NASH的作用及机制研究
-
批准号:JCZRYB202500811
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位: